The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Phenylketonuria (PKU)-Global Market Insights and Sales Trends 2025
Synopsis
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global Phenylketonuria (PKU) market size is expected to reach US$ 2653.6 million by 2029, growing at a CAGR of 10.2% from 2023 to 2029. The market is mainly driven by the significant applications of Phenylketonuria (PKU) in various end use industries. The expanding demands from the Household and Hospital, are propelling Phenylketonuria (PKU) market. Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supplements segment is estimated at % CAGR for the next seven-year period.
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Phenylketonuria (PKU), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Phenylketonuria (PKU) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Phenylketonuria (PKU) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Phenylketonuria (PKU) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Phenylketonuria (PKU) covered in this report include Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives and Firstplay Dietary, etc.
The global Phenylketonuria (PKU) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Global Phenylketonuria (PKU) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Phenylketonuria (PKU) market, Segment by Type:
Medications
Supplements
Others
Global Phenylketonuria (PKU) market, by Application
Household
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Phenylketonuria (PKU) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global Phenylketonuria (PKU) market size is expected to reach US$ 2653.6 million by 2029, growing at a CAGR of 10.2% from 2023 to 2029. The market is mainly driven by the significant applications of Phenylketonuria (PKU) in various end use industries. The expanding demands from the Household and Hospital, are propelling Phenylketonuria (PKU) market. Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supplements segment is estimated at % CAGR for the next seven-year period.
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Phenylketonuria (PKU), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Phenylketonuria (PKU) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Phenylketonuria (PKU) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Phenylketonuria (PKU) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Phenylketonuria (PKU) covered in this report include Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives and Firstplay Dietary, etc.
The global Phenylketonuria (PKU) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Global Phenylketonuria (PKU) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Phenylketonuria (PKU) market, Segment by Type:
Medications
Supplements
Others
Global Phenylketonuria (PKU) market, by Application
Household
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Phenylketonuria (PKU) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Phenylketonuria (PKU) Market Overview
1.1 Phenylketonuria (PKU) Product Overview
1.2 Phenylketonuria (PKU) Market Segment by Type
1.2.1 Medications
1.2.2 Supplements
1.2.3 Others
1.3 Global Phenylketonuria (PKU) Market Size by Type
1.3.1 Global Phenylketonuria (PKU) Market Size Overview by Type (2018-2029)
1.3.2 Global Phenylketonuria (PKU) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Phenylketonuria (PKU) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Phenylketonuria (PKU) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Phenylketonuria (PKU) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Phenylketonuria (PKU) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Phenylketonuria (PKU) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Phenylketonuria (PKU) Sales Breakdown by Type (2018-2023)
2 Global Phenylketonuria (PKU) Market Competition by Company
2.1 Global Top Players by Phenylketonuria (PKU) Sales (2018-2023)
2.2 Global Top Players by Phenylketonuria (PKU) Revenue (2018-2023)
2.3 Global Top Players by Phenylketonuria (PKU) Price (2018-2023)
2.4 Global Top Manufacturers Phenylketonuria (PKU) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Phenylketonuria (PKU) Market Competitive Situation and Trends
2.5.1 Phenylketonuria (PKU) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Phenylketonuria (PKU) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phenylketonuria (PKU) as of 2022)
2.7 Date of Key Manufacturers Enter into Phenylketonuria (PKU) Market
2.8 Key Manufacturers Phenylketonuria (PKU) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Phenylketonuria (PKU) Status and Outlook by Region
3.1 Global Phenylketonuria (PKU) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Phenylketonuria (PKU) Historic Market Size by Region
3.2.1 Global Phenylketonuria (PKU) Sales in Volume by Region (2018-2023)
3.2.2 Global Phenylketonuria (PKU) Sales in Value by Region (2018-2023)
3.2.3 Global Phenylketonuria (PKU) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Phenylketonuria (PKU) Forecasted Market Size by Region
3.3.1 Global Phenylketonuria (PKU) Sales in Volume by Region (2024-2029)
3.3.2 Global Phenylketonuria (PKU) Sales in Value by Region (2024-2029)
3.3.3 Global Phenylketonuria (PKU) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Phenylketonuria (PKU) by Application
4.1 Phenylketonuria (PKU) Market Segment by Application
4.1.1 Household
4.1.2 Hospital
4.2 Global Phenylketonuria (PKU) Market Size by Application
4.2.1 Global Phenylketonuria (PKU) Market Size Overview by Application (2018-2029)
4.2.2 Global Phenylketonuria (PKU) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Phenylketonuria (PKU) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Phenylketonuria (PKU) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Phenylketonuria (PKU) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Phenylketonuria (PKU) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Phenylketonuria (PKU) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Phenylketonuria (PKU) Sales Breakdown by Application (2018-2023)
5 North America Phenylketonuria (PKU) by Country
5.1 North America Phenylketonuria (PKU) Historic Market Size by Country
5.1.1 North America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Phenylketonuria (PKU) Sales in Volume by Country (2018-2023)
5.1.3 North America Phenylketonuria (PKU) Sales in Value by Country (2018-2023)
5.2 North America Phenylketonuria (PKU) Forecasted Market Size by Country
5.2.1 North America Phenylketonuria (PKU) Sales in Volume by Country (2024-2029)
5.2.2 North America Phenylketonuria (PKU) Sales in Value by Country (2024-2029)
6 Europe Phenylketonuria (PKU) by Country
6.1 Europe Phenylketonuria (PKU) Historic Market Size by Country
6.1.1 Europe Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Phenylketonuria (PKU) Sales in Volume by Country (2018-2023)
6.1.3 Europe Phenylketonuria (PKU) Sales in Value by Country (2018-2023)
6.2 Europe Phenylketonuria (PKU) Forecasted Market Size by Country
6.2.1 Europe Phenylketonuria (PKU) Sales in Volume by Country (2024-2029)
6.2.2 Europe Phenylketonuria (PKU) Sales in Value by Country (2024-2029)
7 Asia-Pacific Phenylketonuria (PKU) by Region
7.1 Asia-Pacific Phenylketonuria (PKU) Historic Market Size by Region
7.1.1 Asia-Pacific Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Phenylketonuria (PKU) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Phenylketonuria (PKU) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Phenylketonuria (PKU) Forecasted Market Size by Region
7.2.1 Asia-Pacific Phenylketonuria (PKU) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Phenylketonuria (PKU) Sales in Value by Region (2024-2029)
8 Latin America Phenylketonuria (PKU) by Country
8.1 Latin America Phenylketonuria (PKU) Historic Market Size by Country
8.1.1 Latin America Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Phenylketonuria (PKU) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Phenylketonuria (PKU) Sales in Value by Country (2018-2023)
8.2 Latin America Phenylketonuria (PKU) Forecasted Market Size by Country
8.2.1 Latin America Phenylketonuria (PKU) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Phenylketonuria (PKU) Sales in Value by Country (2024-2029)
9 Middle East and Africa Phenylketonuria (PKU) by Country
9.1 Middle East and Africa Phenylketonuria (PKU) Historic Market Size by Country
9.1.1 Middle East and Africa Phenylketonuria (PKU) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Phenylketonuria (PKU) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Phenylketonuria (PKU) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Phenylketonuria (PKU) Forecasted Market Size by Country
9.2.1 Middle East and Africa Phenylketonuria (PKU) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Phenylketonuria (PKU) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biomarin
10.1.1 Biomarin Company Information
10.1.2 Biomarin Introduction and Business Overview
10.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Biomarin Phenylketonuria (PKU) Products Offered
10.1.5 Biomarin Recent Development
10.2 Mead Johnson
10.2.1 Mead Johnson Company Information
10.2.2 Mead Johnson Introduction and Business Overview
10.2.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mead Johnson Phenylketonuria (PKU) Products Offered
10.2.5 Mead Johnson Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Phenylketonuria (PKU) Products Offered
10.3.5 Abbott Recent Development
10.4 Nutricia
10.4.1 Nutricia Company Information
10.4.2 Nutricia Introduction and Business Overview
10.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Nutricia Phenylketonuria (PKU) Products Offered
10.4.5 Nutricia Recent Development
10.5 Dr. Schär
10.5.1 Dr. Schär Company Information
10.5.2 Dr. Schär Introduction and Business Overview
10.5.3 Dr. Schär Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Dr. Schär Phenylketonuria (PKU) Products Offered
10.5.5 Dr. Schär Recent Development
10.6 Vitaflo
10.6.1 Vitaflo Company Information
10.6.2 Vitaflo Introduction and Business Overview
10.6.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vitaflo Phenylketonuria (PKU) Products Offered
10.6.5 Vitaflo Recent Development
10.7 Cambrooke
10.7.1 Cambrooke Company Information
10.7.2 Cambrooke Introduction and Business Overview
10.7.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cambrooke Phenylketonuria (PKU) Products Offered
10.7.5 Cambrooke Recent Development
10.8 PKU Perspectives
10.8.1 PKU Perspectives Company Information
10.8.2 PKU Perspectives Introduction and Business Overview
10.8.3 PKU Perspectives Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 PKU Perspectives Phenylketonuria (PKU) Products Offered
10.8.5 PKU Perspectives Recent Development
10.9 Firstplay Dietary
10.9.1 Firstplay Dietary Company Information
10.9.2 Firstplay Dietary Introduction and Business Overview
10.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Firstplay Dietary Phenylketonuria (PKU) Products Offered
10.9.5 Firstplay Dietary Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Phenylketonuria (PKU) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Phenylketonuria (PKU) Industrial Chain Analysis
11.4 Phenylketonuria (PKU) Market Dynamics
11.4.1 Phenylketonuria (PKU) Industry Trends
11.4.2 Phenylketonuria (PKU) Market Drivers
11.4.3 Phenylketonuria (PKU) Market Challenges
11.4.4 Phenylketonuria (PKU) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Phenylketonuria (PKU) Distributors
12.3 Phenylketonuria (PKU) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
